1 Introduction Recent advances in immunotherapy have demonstrated the potential of targeting the tumour immune microenvironment (TIME), with evidence of improved clinical outcomes for patients [1, 2]. TIME varies from individual to individual and is closely associated with patient prognosis.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Shotaro
Contact Shotaro, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack